Search results for “Thioredoxin reductase” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 204 patents, we discovered top 59 key players by total patent application. Syngenta Participations AG, Cancer Research Ventures Ltd., Noevir Co., Ltd. are dominant in this area. They take 30.88% of the total patent filing.
Syngenta Participations AG
Switzerland
Patent: 28
Cancer Research Ventures Ltd.
United Kingdom
Patent: 22
Noevir Co., Ltd.
Hyogo-ken, Japan
Patent: 13
Kaixi Pharmaceutical (Wuhan) Co., Ltd.
Hubei Sheng, China
Patent: 12
Sutro Biopharma, Inc.
California, United States
Patent: 10
Xencor, Inc.
California, United States
Patent: 9
Wuhan Shangyi Health Technology Co., Ltd.
Hubei Sheng, China
Patent: 9
CINDA PHARMA AB
Sweden
Patent: 7
Thioredoxin Systems AB
Sweden
Patent: 6
Nanjing Kaixi Medical Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 6
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 4 patents, we discovered top 2 start-ups by total patent application.
STARTUP
Oblique Therapeutics AB
Sweden
Patent: 2
STARTUP
GeneMedicine
South Korea
Patent: 2
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 82 patents applied in the last 5 years. We discover 38 most active companies in this area. The fast-growing Sutro Biopharma, Inc., Lanzhou University, CINDA PHARMA AB take 30.49% of patent filing during this period.
Sutro Biopharma, Inc.
California, United States
Patent: 10
Lanzhou University
Gansu Sheng, China
Patent: 8
CINDA PHARMA AB
Sweden
Patent: 7
Benson Hill, Inc.
Missouri, United States
Patent: 4
Wacker GmbH
Berlin, Germany
Patent: 4
Nantong University
Jiangsu Sheng, China
Patent: 3
Kao Corp.
Tokyo-to, Japan
Patent: 3
Kaixi Pharmaceutical (Wuhan) Co., Ltd.
Hubei Sheng, China
Patent: 3
University of Sharjah
United Arab Emirates
Patent: 3
TriAct Therapeutics, Inc.
California, United States
Patent: 2
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 82 patents in last 5 years, we discover 32 new entrants. Sutro Biopharma, Inc., Lanzhou University, CINDA PHARMA AB are the most active new entrants in this area.
Sutro Biopharma, Inc.
California, United States
Patent: 10
Lanzhou University
Gansu Sheng, China
Patent: 8
CINDA PHARMA AB
Sweden
Patent: 7
Benson Hill, Inc.
Missouri, United States
Patent: 4
Wacker GmbH
Berlin, Germany
Patent: 4
Nantong University
Jiangsu Sheng, China
Patent: 3
Kao Corp.
Tokyo-to, Japan
Patent: 3
University of Sharjah
United Arab Emirates
Patent: 3
TriAct Therapeutics, Inc.
California, United States
Patent: 2
Portland State University
Oregon, United States
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 145 patents, we discovered top 27 universities and scientific research institutions by total patent application. University of Hong Kong, Lanzhou University, Warszawski Uniwersytet Medyczny are dominant in this area. They take 36.55% of the total patent filing.
University of Hong Kong
Hong Kong SAR, China
Patent: 8
Lanzhou University
Gansu Sheng, China
Patent: 8
Warszawski Uniwersytet Medyczny
Mazowieckie, Poland
Patent: 7
Duke University
North Carolina, United States
Patent: 6
University of Sunderland
Cumbria, United Kingdom
Patent: 5
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 3
University of Sharjah
United Arab Emirates
Patent: 3
Nantong University
Jiangsu Sheng, China
Patent: 3
University of Dortmund
Nordrhein-Westfalen, Germany
Patent: 3
Sun Yat-Sen University
Guangdong Sheng, China
Patent: 2
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: